In its second respiratory-focused deal of the month, Clario is partnering with Strados Labs to use its FDA-approved monitoring device for clinical trials. Under the agreement, Philadelphia-based ...

Opinions expressed by Digital Journal contributors are their own. As healthcare systems worldwide continue to address the effects of the COVID-19 pandemic, pharmaceutical companies like Amneal ...

Annually, a staggering 20 million individuals globally find themselves connected to invasive respiratory support systems like ECMO and CBP. These systems, while crucial for survival, often necessitate ...

Sanofi to pay $1.15 billion upfront for Vicebio, with up to $450 million in milestone payments. Vicebio’s VXB-241 RSV-hMPV combo vaccine is in Phase 1 trials in older adults. Get the data-driven ...

Each winter, respiratory illness was once a predictable event: a rise in flu, a scattering of RSV cases, and a measurable but contained increase in hospital admissions. That rhythm no longer exists.

The Nigerian Thoracic Society has called for greater use of technology to close gaps in respiratory healthcare across the country. The message was at the centre of the society’s scientific conference ...